Twist Bioscience Corporation
TWST
$39.96
$0.842.15%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 4.73% | 3.98% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.73% | 3.98% | |||
| Cost of Revenue | -1.30% | 0.61% | |||
| Gross Profit | 12.05% | 8.40% | |||
| SG&A Expenses | 5.71% | -6.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.16% | -3.75% | |||
| Operating Income | 3.88% | 18.07% | |||
| Income Before Tax | 9.36% | 59.30% | |||
| Income Tax Expenses | 201.04% | -150.26% | |||
| Earnings from Continuing Operations | 8.83% | 59.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.83% | 59.50% | |||
| EBIT | 3.88% | 18.07% | |||
| EBITDA | 11.64% | 10.38% | |||
| EPS Basic | 9.77% | 59.79% | |||
| Normalized Basic EPS | 10.30% | 14.70% | |||
| EPS Diluted | 9.77% | 59.79% | |||
| Normalized Diluted EPS | 10.30% | 14.70% | |||
| Average Basic Shares Outstanding | 1.04% | 0.70% | |||
| Average Diluted Shares Outstanding | 1.04% | 0.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
